Three RI-MUHC members named in the first-ever List of Canadian women leaders in global health
On November 20, the Canadian Society for International Health released its first Canadian...
Dr. Emily G. McDonald honoured by the Women’s Y Foundation
During an event held at the Écomusée du Fier Monde on October 25, the Women’s Y Foundation honoured Dr. Emily G. McDonald...
Two awards for Dr. Robyn Tamblyn
Over the last several months Robyn Tamblyn, PhD, senior scientist at the Research Institute of the McGill University Health Centre...
Madhukar Pai invited to first-ever UN High Level Meeting on Tuberculosis
Dr. Madhukar Pai, Director of McGill's International Tuberculosis Centre, Director of McGill Global Health Programs and a scientist at the...
The Journey of a USBJI Young Investigator in Research
In the September edition of the United States Bone and Joint Initiative (USBJI) Newsletter, Sasha Bernatsky, MD, PhD, FRCPC...
Life-saving epinephrine underused during anaphylaxis outside of hospital, study finds
Fewer than half of adults and children experiencing food-induced anaphylaxis use their epinephrine autoinjector (EAI) before being...
Latent TB Treatment: Shorter is Better
Treatment of latent tuberculosis (TB) is set to transform after two studies from the Research Institute of the McGill University Health Centre...
Canadians are aging well, but ...
It's not every day that one receives a call from a researcher asking if they want to participate in a study on aging for the next 20 years of their...
Living with the stigma of diabetes
Michael Wright was your average high school student, juggling the responsibilities of school and friends while taking the first steps towards...
Arthritis Drugs Potentially Safe for Expectant Mothers
A new study led by a team at the Research Institute of the MUHC (RI-MUHC) in Montreal has revealed that pregnant women with...